cardiovascular risk

FDA Approves Ozempic for Chronic Kidney Disease Treatment, Showing 24% Risk Reduction in Severe Kidney Outcomes

Washington, January 30 – The U.S. Food and Drug Administration (FDA) has granted approval for Novo Nordisk’s Ozempic to be…